Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group AT-hook 1 pseudogene 1 (HMGA1P1) is a processed pseudogene related to the HMGA1 gene, found on chromosome Xp21.3 in humans. While pseudogenes are generally considered noncoding genomic relics, some—including HMGA1P1—may produce RNA or even encode proteins detectable with HMGA1 antibodies, although these have post-translational differences relative to wild-type HMGA1. HMGA1P1 may function as a competitor protein, potentially modulating the activity of HMGA1 in chromatin remodeling, but its exact biological role and protein translation are not fully confirmed. Chromosomal rearrangements involving HMGA1P1 have been seen in several benign tumors, suggesting possible disease relevance. However, there is currently no evidence that HMGA1P1 is a direct therapeutic target, nor are there any known drugs or mechanisms of action that modulate its activity. Further research is needed to clarify its molecular functions and any clinical utility.\n\nKey clarifications:\n- HMGA1P1 is a pseudogene, not a conventional protein-coding gene or therapeutic target.\n- Its biological functions and disease roles are incompletely understood; most evidence relates to regulatory effects (possibly affecting HMGA1 expression) and associations with chromosomal rearrangements in tumors, but not direct drug targeting.\n- There are no established drug interactions, mechanisms of action, or clinical biomarkers for HMGA1P1.\n- The HMGA1 protein (not pseudogene) is a well-known transcriptional regulator involved in chromatin architecture, cell cycle, and is implicated in various cancers, but pseudogenes like HMGA1P1 act primarily through regulatory, competitive, or genomic mechanisms—when they are active at all.\nIf precise gene/protein targeting is required, HMGA1 (not HMGA1P1) should be considered. HMGA1P1 is not a therapeutic target in the conventional sense, and \"is_incorrect\" is set to true due to lack of evidence that HMGA1P1 is a recognized druggable target or established biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group AT-hook 1 pseudogene 1 (HMGA1P1).